Phraew Sakon

Gmail Google Apps Microsoft Office 365 OneTrust Active Campaign Remote AI

healthcare health & wellness biotechnology life sciences major pharmaceuticals health care oncology therapeutics biopharmaceutical cancer treatment clinical trials bioinformatics fda approved research & development drug pipeline drug candidates hemato-oncology solid tumors biologics targeted therapy elzonris orserdu patient access expanded access first-in-class estrogen receptor serum biomarkers innovative therapies pharmaceuticals cancer immunotherapy pediatric oncology adult oncology biological agents antibody-drug conjugates xpo1 inhibitors novel compounds healthcare collaboration patient outcomes translational medicine therapeutic areas malignancies safety & efficacy regulatory approvals biomarkers hematological malignancies survival rates biotech partnerships patient management programs complementary therapies chemotherapy resistance metastatic breast cancer therapeutic solutions biopharma initiatives molecular targeting oncology therapeutics biopharmaceuticals cancer treatments targeted therapies immunotherapy advanced breast cancer blastic plasmacytoid dendritic cell neoplasm multiple myeloma innovative drug development clinical pipeline personalized medicine unmet medical needs commercial-stage biopharmaceutical company collaboration ai-driven drug discovery therapeutic innovation global market presence cancer care drug commercialization advanced therapies oncology market cancer patient demographics therapeutic focus health wellness & fitness hospital & health care information technology & services medical